{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-233794","form_type":"8-K","ticker":"NUVB","cik":"0001811063","company_name":"Nuvation Bio Inc.","filed_at":"2024-10-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.741230+00:00","generated_at":"2026-05-30T19:25:20.700084+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Nuvation Bio appoints Philippe Sauvage as CFO effective October 7, 2024","bullets":["Philippe Sauvage appointed CFO; previously SVP Global Head of Operations & Access at Sanofi (2020-2024).","Initial annual base salary of $510,000; annual discretionary bonus up to 45% of base.","Option award for 750,000 shares; vests 1/4 on one-year anniversary, then monthly vesting.","Severance: 12 months base salary plus COBRA reimbursement; change-in-control double trigger with full equity acceleration.","No family relationships or material transactions with directors or officers disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-233794","json":"https://secwatch.observer/filing/0001193125-24-233794.json","markdown":"https://secwatch.observer/filing/0001193125-24-233794.md","text":"https://secwatch.observer/filing/0001193125-24-233794.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1811063/000119312524233794/0001193125-24-233794-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1811063/000119312524233794/d787897d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T19:25:20.700084+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e367d1d364","claim":"Philippe Sauvage was appointed as Chief Financial Officer at Nuvation Bio Inc..","evidence_excerpt":"Effective October 7, 2024 (the “Appointment Date”), the Board of Nuvation Bio Inc. (the “Company”) appointed Philippe Sauvage as the Company’s Chief Financial Officer and Principal Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1811063/000119312524233794/0001193125-24-233794-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}